Long-Acting Antibacterial Hydrogels Constructed by Interface-Induced Directional Assembly
Source abstract
Abstract
Self-assembled supermolecular hydrogels of therapeutic agents without structural modification are of great significance in biomedical applications. Nevertheless, the complex conformations and elusive interactions of therapeutic molecules limit the controlled assembly of hydrogels. Molecules at the interface might have different arrangements and assemblies compared to those in bulk aqueous solution, which could potentially alter the selectivity of supramolecular polymorphs. However, this effect is still not well understood. Here, we demonstrate the interface-induced self-assembly of fibers for hydrogels, which is distinct from the spherical aggregates in the bulk aqueous solution, using cephradine (CEP) as a model compound. This phenomenon is caused by the packing of anisotropic molecules at the interface, and it can be applied to control the supramolecular polymorphism for the direct self-assembly of hydrogels of therapeutic agents. The interface-induced hydrogel exhibits a high degree of adjustable release and a long-acting bactericidal effect.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Supramolecular Self-Assembly in Materials · Polydiacetylene-based materials and applications · Lipid Membrane Structure and Behavior
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
National Engineering Research Center of Industrial Crystallization Technology, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China
Collaborative Innovation Center of Chemical Science and Engineering (Tianjin), Tianjin 300072, China
State Key Laboratory of Chemical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China
Funding
National Natural Science Foundation of China
References (58)
Show source-provided references
1. 10.1016/j.mattod.2015.10.00810.1016/j.mattod.2015.10.008 ↗
2. 10.1016/j.tibtech.2018.04.00410.1016/j.tibtech.2018.04.004 ↗
3. 10.3390/pharmaceutics1004019110.3390/pharmaceutics10040191 ↗
4. 10.1021/acsnano.1c0420610.1021/acsnano.1c04206 ↗
5. 10.1021/acs.chemrev.1c0081510.1021/acs.chemrev.1c00815 ↗
6. 10.1016/j.addr.2005.09.01910.1016/j.addr.2005.09.019 ↗
7. 10.1002/adma.20160114710.1002/adma.201601147 ↗
8. 10.1039/b806410p10.1039/b806410p ↗
9. 10.1007/s12274-018-1994-z10.1007/s12274-018-1994-z ↗
10. 10.1039/C7CS00515F10.1039/C7CS00515F ↗
11. 10.1073/pnas.173060910010.1073/pnas.1730609100 ↗
12. 10.1371/journal.pbio.006001710.1371/journal.pbio.0060017 ↗
13. 10.1039/B616563J10.1039/B616563J ↗
14. 10.1039/b507314f10.1039/b507314f ↗
15. 10.1016/j.tetlet.2006.08.00210.1016/j.tetlet.2006.08.002 ↗
16. 10.1016/j.biomaterials.2008.09.04510.1016/j.biomaterials.2008.09.045 ↗
17. 10.1039/b609047h10.1039/b609047h ↗
18. 10.1039/C4RA03688C10.1039/C4RA03688C ↗
19. 10.1039/b807346e10.1039/b807346e ↗
20. 10.1021/acs.iecr.2c0342410.1021/acs.iecr.2c03424 ↗
21. 10.1016/j.drudis.2006.05.01410.1016/j.drudis.2006.05.014 ↗
22. 10.1039/C2CS35284B10.1039/C2CS35284B ↗
23. 10.1039/C5CS00093A10.1039/C5CS00093A ↗
24. 10.1021/ar500105t10.1021/ar500105t ↗
25. 10.1021/acs.langmuir.2c0006510.1021/acs.langmuir.2c00065 ↗
26. 10.1021/jacs.2c0262310.1021/jacs.2c02623 ↗
27. 10.1016/j.eng.2021.02.00410.1016/j.eng.2021.02.004 ↗
28. 10.1002/agt2.28310.1002/agt2.283 ↗
29. 10.1039/D1CE01486B10.1039/D1CE01486B ↗
30. Qing-Hua G. E. · Chinese Pharm. J. · 2009 · 40 · 429
31. 10.1021/acs.iecr.2c0462410.1021/acs.iecr.2c04624 ↗
32. 10.1016/j.molliq.2019.11231210.1016/j.molliq.2019.112312 ↗
33. 10.1021/jacs.2c0323010.1021/jacs.2c03230 ↗
34. 10.1038/nprot.2016.01010.1038/nprot.2016.010 ↗
35. 10.1038/nchem.212910.1038/nchem.2129 ↗
36. 10.1038/s41467-019-09601-310.1038/s41467-019-09601-3 ↗
37. 10.1039/C7CP02110K10.1039/C7CP02110K ↗
38. 10.1002/jcc.2681210.1002/jcc.26812 ↗
39. 10.1002/anie.20221334510.1002/anie.202213345 ↗
40. 10.1016/j.nantod.2011.10.00510.1016/j.nantod.2011.10.005 ↗
41. 10.1179/1743280411Y.000000001510.1179/1743280411Y.0000000015 ↗
42. 10.1038/s41586-020-2161-810.1038/s41586-020-2161-8 ↗
43. 10.1021/acsnano.9b0201010.1021/acsnano.9b02010 ↗
44. 10.1016/j.fluid.2017.02.01710.1016/j.fluid.2017.02.017 ↗
45. 10.1107/S010827011302686310.1107/S0108270113026863 ↗
46. 10.1002/anie.20180282510.1002/anie.201802825 ↗
47. Svergun D. I. · 1987
48. 10.1038/s41467-020-15422-610.1038/s41467-020-15422-6 ↗
49. 10.1007/BF0184013210.1007/BF01840132 ↗
50. Glatter O. · 1982
51. 10.1021/ja00203a00810.1021/ja00203a008 ↗
52. 10.1016/j.saa.2020.11897610.1016/j.saa.2020.118976 ↗
53. 10.1366/000370200195047210.1366/0003702001950472 ↗
54. 10.1021/acs.cgd.8b0172810.1021/acs.cgd.8b01728 ↗
55. 10.1002/anie.20191178210.1002/anie.201911782 ↗
56. 10.1038/nbt0298-15310.1038/nbt0298-153 ↗
57. 10.1038/s41578-019-0111-610.1038/s41578-019-0111-6 ↗
58. 5 - Mathematical Models of Drug Release; Woodhead Publishing: 2015, pp. 6386.